Arcturus Therapeutics (ARCT) Q1 2026 Earnings

3MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.18
-0.9
-0.62
-0.34

Details

Expected EPS
-0.776878
Actual EPS
-1.03
Surprise EPS
-0.25
Surprise Percent
+32.58%

Description

Arcturus Therapeutics (ARCT) has reported earnings of -1.03 per share for Q1 2026.

0 Comments

Share your thoughts